On the day that Internet-search company

Google

(GOOG) - Get Alphabet Inc. Class C Report

closed above $300 for the first time, Jim Cramer said on

CNBC's

"Mad Money" that the stock has more room to rise.

"The bottom line is Google is not done," Cramer said. He said Google had a "weigh-station stop" at $300, but he believes the stock will reach $350 a share. "Google is cheap," he said. "Stocks trade on growth. And there is no company that has the growth that Google has."

In response to a question from a caller, Cramer said he thinks "many people are selling

Yahoo!

(YHOO)

to buy Google." He also spoke positively about

Intel

(INTC) - Get Intel Corporation (INTC) Report

,

Microsoft

(MSFT) - Get Microsoft Corporation (MSFT) Report

and

Cisco

(CSCO) - Get Cisco Systems, Inc. Report

, saying that "in the second half of the year tech has always come back."

However, Cramer was downbeat on

IBM

(IBM) - Get International Business Machines (IBM) Report

, saying it wasn't the tech stock to own.

Away from the technology sector, Cramer said he was positive on

Boeing

(BA) - Get Boeing Company Report

,

St. Jude Medical

(STJ)

,

Constellation Brands

(STZ) - Get Constellation Brands, Inc. Class A Report

and

Treehouse

, a pending spinoff from

Dean Foods

(DF) - Get Dean Foods Company Report

. With Treehouse, he recommended investors wait for three days after the stock goes public to buy it, because at the outset the shares could see forced selling by money managers who track the

S&P 500

.

Another caller asked if she should consider

Cadbury Schweppes

(CSG)

, but Cramer said

Pepsi

(PEP) - Get PepsiCo, Inc. Report

was better. "Those who want a beverage company should look no further than Pepsi," he said.

In the lightning round, Cramer said he liked

Odyssey Re

(ORH)

,

XTO Energy

( XTO),

Timberland

( TBL),

Nike

(NKE) - Get NIKE, Inc. (NKE) Report

,

Novatel

(NVTL)

,

TurboChef

( OVEN) and

Lucent

( LU).

Image placeholder title

Also getting upbeat comments were

McAfee

( MFE),

Deere

(DE) - Get Deere & Company Report

,

Bowater

( BOW),

Calpine

(CPN)

,

Disney

(DIS) - Get Walt Disney Company Report

,

Marvell Technology

(MRVL) - Get Marvell Technology Group Ltd. Report

,

Broadcom

undefined

,

Texas Instruments

(TXN) - Get Texas Instruments Incorporated Report

,

National Semiconductor

(NSM)

,

Tesoro

(TSO)

,

Lockheed Martin

(LMT) - Get Lockheed Martin Corporation (LMT) Report

,

Northrop Grumman

(NOC) - Get Northrop Grumman Corporation Report

,

Alliant Techsystems

(ATK)

,

Enterra Energy

(EENC)

and

Sears Holdings

(SHLD)

.

Cramer offered bearish opinions on

Archer Daniels Midland

(ADM) - Get Archer-Daniels-Midland Company Report

,

NitroMed

( NTMD),

Powerwave Technologies

(PWAV)

,

Cognos

( COGN),

Audible

( ADBL),

Wind River

( WIND),

Presstek

( PRST),

Johnson Controls

(JCI) - Get Johnson Controls International plc (JCI) Report

,

Orbital Sciences

(ORB)

,

Verizon

(VZ) - Get Verizon Communications Inc. Report

,

Regeneron Pharmaceuticals

(REGN) - Get Regeneron Pharmaceuticals, Inc. Report

,

Dreamworks

(DWA)

,

Nordic American Tanker

(NAT) - Get Nordic American Tankers Limited Report

,

Aspect Communications

(ASPT)

,

Redback

( RBAK),

Kana

(KANAE)

and

Ameritrade

(AMTD) - Get TD Ameritrade Holding Corporation Report

.

Additionally, Cramer said he still likes the homebuilders, including names like

Lennar

(LEN) - Get Lennar Corporation Class A Report

,

Toll Brothers

(TOL) - Get Toll Brothers, Inc. Report

and

KB Home

(KBH) - Get KB Home Report

.

Friday, June 24

Technology shares are poised to rally while oil and health care stocks are probably "done going down" after a two-day drubbing that lopped 2.7% off the

Dow

, Jim Cramer said on

CNBC's

"Mad Money" Friday night. Cramer warned against energy-reliant cyclical companies.

"The last two days, technology did better than cyclicals. That will be the pattern from here," Cramer said. "I switched my plan this week. I'm tired of making money in retail. It's time to take that money and put it in technology."

Cramer said too much optimism brought down the market this week as psychology got ahead of fundamentals.

"The market is getting killed because there's too many bulls. When everyone's so bullish, there's nobody left to convert," he said. "Everyone who wants to be in, is already in. The shorts were forced to cover earlier. They can't be the safety net that they could be earlier."

Still, the action in some sectors is better than others.

"We started seeing at the end of the week that companies that don't use a lot of oil were bottoming while companies that do

kept falling."

To harvest the coming upside, Cramer told viewers to "stop whining" about IT outsourcing and consider buying companies that can sell technology services cheaply, particularly ones based in India.

The business model works in a global economy because "wherever there are phone lines, you can outsource brainpower." Cramer prefers India to China because its information services infrastructure is already mature and the country doesn't have as many political headaches.

Cramer highlighted three names in the space,

Cognizant

(CTSH) - Get Cognizant Technology Solutions Corporation Class A Report

,

Wipro

(WIT) - Get Wipro Limited Sponsored ADR Report

and

Infosys

( DNA).

"Infosys is the pure play and it's the one I would run with," he said. He noted management problems have left Wipro cheapest on a price-to-earnings basis because of management trouble, and said Cognizant might be too levered to the financial sector.

"Infosys is cheaper. I still think Cognizant is going up, I just think Infosys is going up more," Cramer said. "That said, I'd buy either hand-over-fist on any kind of major pullback."

In pharmaceuticals, Cramer highlighted

Genentech

( DNA) and

TheStreet Recommends

Sanofi

(SNY) - Get Sanofi Sponsored ADR Report

as possible beneficiaries of new research showing chemotherapy is more effective in non-small cell lung cancer patients than previously believed.

While neither have obvious revenue streams in chemo, both have cancer candidates (Taxotere at Sanofi and Tarceva and Avastin at Genentech) that could see increased referrals in the event of more chemo treatments.

"When it comes to cancer, these drugs act like good little socialists. It's all about cooperation." Cramer said he'd "back up the truck" on Genentech.

Cramer was bearish on drug companies

Alkermes

(ALKS) - Get Alkermes Plc Report

and

Cephalon

( CEPH), which recently signed a deal to market an anti-alcoholism treatment.

In the lightning round, Cramer was upbeat about

Allstate

(ALL) - Get Allstate Corporation Report

,

Medarex

( MEDX),

Kellwood

( KWD),

Sunrise Senior

( SRZ),

Boeing

(BA) - Get Boeing Company Report

,

BE Aerospace

(BEAV)

,

Sonic

(SONC)

,

McGraw-Hill

( MHP),

McDonald's

(MCD) - Get McDonald's Corporation (MCD) Report

,

Kaneb Pipeline

(KPP)

,

Whirlpool

(WHP)

,

Procter & Gamble

(PG) - Get Procter & Gamble Company Report

and

ITT Industries

(ITT) - Get ITT, Inc. Report

.

He recommended selling

Shanda

( SNDA),

Diebold

(DBD) - Get Diebold Nixdorf Incorporated Report

,

Salesforce

(CRM) - Get salesforce.com, inc. Report

,

Nextel

( NXTL),

Amedisys

(AMED) - Get Amedisys, Inc. Report

,

Red Robin

(RRGB) - Get Red Robin Gourmet Burgers, Inc. Report

,

Rockwell Collins

(COL)

,

Corn Products

( CPO),

Maytag

( MYG),

Ceradyne

( CRDN),

Able Labs

( ABRX) and

Netflix

(NFLX) - Get Netflix, Inc. (NFLX) Report

.

Image placeholder title

June 23 'Mad Money'

On

CNBC's

"Mad Money" Thursday, Jim Cramer said the market had a "first-class panic" Thursday, featuring a 166-plus point decline in the

Dow Jones Industrial Average

. "The market is throwing a sale and it's not discriminating between what needs oil lower and what doesn't," he said in the opening monologue. "Let's discriminate and get ready to do some buying."

In a Cramer-esque version of the paired trade, the television host laid out a number of stocks that "aren't working" and should be sold and recommended corresponding names that should be bought instead.

Cramer said the market "wants out" of stocks such as Tyco -- "which needs fast GDP growth we may not have anymore" -- and wants into UnitedHealth , which helps keep health care costs down.

"People should swap out of AMR and go into Halliburton ," he said.

"Get out of Ford and into Genentech ( DNA)," he said, calling Ford above $10 "a gift."

"Sell Yellow Roadway ( YELL) -- it isn't coming back -- and buy Motorola ( MOT)."

"Sell Southwest Airlines and buy Gillette ."

"Sell CSX and buy General Mills ."

"Sell Dow Chemical and buy Walgreen's ."

"Get out of DuPont and into Bristol-Myers ."

"Bottom line -- people will sell tomorrow," Cramer predicted. "I need you to use the weakness that comes across the board and load 'em up if they're not sensitive to the economy or are in tech."

Cramer reiterated his bullish call on tech, calling it a "six-month call" vs. a daily call. "The market wants you in

Microsoft

(MSFT) - Get Microsoft Corporation (MSFT) Report

, which sells at 19 times earnings," he said. "If it does go down, it's a gift."

Later in the show, he observed relative and absolute strength Thursday in tech names such as Microsoft,

Apple

(AAPL) - Get Apple Inc. (AAPL) Report

,

Broadcom

undefined

, and

Google

(GOOG) - Get Alphabet Inc. Class C Report

. The group was "the rock of Gibraltar today ... that's a sign the buyers will come back to the

Nasdaq

first" after the oil-related selloff ends.

In response to a caller's question about how to profit from $60 oil, Cramer recommended

ConocoPhillips

(COP) - Get ConocoPhillips Report

,

EnCana

(ECA) - Get Encana Corporation Report

and oil service companies Halliburton,

Schlumberger

(SLB) - Get Schlumberger NV Report

,

Baker Hughes

(BHI)

and

Smith International

( SII). However, he later in the show recommended selling

Chevron

(CVX) - Get Chevron Corporation Report

, fearing it'll have to "pay up" for

Unocal

( UCL).

In the Lightning Round, Cramer was upbeat about

WellPoint

(WLP)

,

Quicksilver Resources

(KWK)

,

General Dynamics

(GD) - Get General Dynamics Corporation (GD) Report

,

El Paso

( EP),

Millennium Pharmaceuticals

( MLNM),

Cimarex Energy

(XEC) - Get Cimarex Energy Co. Report

and

Disney

(DIS) - Get Walt Disney Company Report

.

The television host recommended selling

Unova

( UNA),

Southern Peru Copper

( PCU),

IBM

(IBM) - Get International Business Machines (IBM) Report

,

Ameritrade

(AMTD) - Get TD Ameritrade Holding Corporation Report

,

Callaway Golf

(ELY) - Get Callaway Golf Company Report

,

Goodyear Tire

(GT) - Get Goodyear Tire & Rubber Company Report

,

Applied Digital Solutions

( ADSX),

Harris & Harris

(TINY)

,

International Securities Exchange

( ISE),

Manhattan Associates

(MANH) - Get Manhattan Associates, Inc. Report

, and

Kroger

(KR) - Get Kroger Co. (KR) Report

.

Finally, Cramer agreed with

Marketwatch.com

columnist Herb Greenberg's negative stance on

Jarden

(JAH)

.

At the time of publication, Cramer was long Alliant Techsystems, Intel, Lucent, Sears Holdings, Yahoo!, Halliburton, EnCana, Gillette, General Mills and UnitedHealth Group.

James J. Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here. Listen to Cramer's RealMoney Radio show on your computer; just click

here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click

here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict."